| Product Code: ETC8253335 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Central Nervous System (CNS) Stimulants Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Central Nervous System (CNS) Stimulants Market - Industry Life Cycle |
3.4 Mauritius Central Nervous System (CNS) Stimulants Market - Porter's Five Forces |
3.5 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Central Nervous System (CNS) Stimulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Mauritius |
4.2.2 Growing awareness and diagnosis rates for CNS-related conditions |
4.2.3 Rise in healthcare expenditure and investment in healthcare infrastructure in Mauritius |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for CNS stimulants in Mauritius |
4.3.2 Limited availability of skilled healthcare professionals specialized in CNS disorders in the country |
5 Mauritius Central Nervous System (CNS) Stimulants Market Trends |
6 Mauritius Central Nervous System (CNS) Stimulants Market, By Types |
6.1 Mauritius Central Nervous System (CNS) Stimulants Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phendimetrazine, 2021- 2031F |
6.1.4 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phentermine, 2021- 2031F |
6.1.5 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Methamphetamine, 2021- 2031F |
6.1.6 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Dextroamphetamine, 2021- 2031F |
6.1.7 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mauritius Central Nervous System (CNS) Stimulants Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.2.3 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Anxiety Disorders, 2021- 2031F |
6.2.4 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Attention Deficit Hyperactivity Disorder, 2021- 2031F |
6.2.5 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mauritius Central Nervous System (CNS) Stimulants Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mauritius Central Nervous System (CNS) Stimulants Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mauritius Central Nervous System (CNS) Stimulants Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Mauritius Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mauritius Central Nervous System (CNS) Stimulants Market Import-Export Trade Statistics |
7.1 Mauritius Central Nervous System (CNS) Stimulants Market Export to Major Countries |
7.2 Mauritius Central Nervous System (CNS) Stimulants Market Imports from Major Countries |
8 Mauritius Central Nervous System (CNS) Stimulants Market Key Performance Indicators |
8.1 Number of new CNS stimulant drugs approved for sale in Mauritius |
8.2 Percentage increase in the number of healthcare facilities offering CNS disorder treatments |
8.3 Average waiting time for patients seeking treatment for CNS disorders in Mauritius |
9 Mauritius Central Nervous System (CNS) Stimulants Market - Opportunity Assessment |
9.1 Mauritius Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Mauritius Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mauritius Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mauritius Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Mauritius Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Central Nervous System (CNS) Stimulants Market - Competitive Landscape |
10.1 Mauritius Central Nervous System (CNS) Stimulants Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Central Nervous System (CNS) Stimulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here